Oncology is the largest therapeutic area in drug development, accounting for nearly half of the biopharmaceutical industry’s $200 billion per year investment in R&D. Because oncology clinical development is exceptionally competitive, costly, and fast-paced, mastering its unique complexities is essential for success. Join us for this full day workshop intended to guide you through the..
This symposium will highlight emerging strategies and practical considerations in drug metabolism, bioanalysis, and translational sciences for novel therapeutic modalities. As the industry moves beyond traditional small molecules toward increasingly complex platforms — including oligonucleotides, peptides, and antibody–drug conjugates (ADCs) — there is a growing need for fit-for-purpose ADME characterization and advanced analytical approaches. Expert..
Developing effective cancer therapies remains a major challenge, with low translational success despite advances in molecular oncology. A key barrier is the limited predictive power of traditional preclinical models and the need for robust pharmacological evaluation. This workshop addresses these challenges by exploring preclinical models and pharmacology strategies essential for oncology drug development. With the..
The Bio Supply Management Alliance (BSMA) invites global leaders, innovators, and changemakers in biopharma supply chain management to join the 18th Annual BSMA Conference — the industry’s premier gathering for advancing the future of life sciences supply chains. With more than 200 companies represented and over 350 subject matter experts, executives, service providers, and technology..
This workshop will cover all key functions of Chemistry, Manufacturing and Control (CMC) of recombinant protein and antibody therapeutics. Designed for both experts seeking cross-functional insights and new entrants from academia or industry, it will provide a clear understanding of how all CMC functions connect. The attendees will gain a knowledge of the current best..